Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 5
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Viral Vector Vaccines against Bluetongue Virus.
Jiménez-Cabello L, Utrilla-Trigo S, Calvo-Pinilla E, Moreno S, Nogales A, Ortego J, Marín-López A. Jiménez-Cabello L, et al. Microorganisms. 2020 Dec 25;9(1):42. doi: 10.3390/microorganisms9010042. Microorganisms. 2020. PMID: 33375723 Free PMC article. Review.
Inhibition of Orbivirus Replication by Aurintricarboxylic Acid.
Alonso C, Utrilla-Trigo S, Calvo-Pinilla E, Jiménez-Cabello L, Ortego J, Nogales A. Alonso C, et al. Among authors: jimenez cabello l. Int J Mol Sci. 2020 Oct 2;21(19):7294. doi: 10.3390/ijms21197294. Int J Mol Sci. 2020. PMID: 33023235 Free PMC article.
A protective bivalent vaccine against Rift Valley fever and bluetongue.
Calvo-Pinilla E, Marín-López A, Moreno S, Lorenzo G, Utrilla-Trigo S, Jiménez-Cabello L, Benavides J, Nogales A, Blasco R, Brun A, Ortego J. Calvo-Pinilla E, et al. Among authors: jimenez cabello l. NPJ Vaccines. 2020 Jul 30;5(1):70. doi: 10.1038/s41541-020-00218-y. eCollection 2020. NPJ Vaccines. 2020. PMID: 32793399 Free PMC article.
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus.
Utrilla-Trigo S, Jiménez-Cabello L, Alonso-Ravelo R, Calvo-Pinilla E, Marín-López A, Moreno S, Lorenzo G, Benavides J, Gilbert S, Nogales A, Ortego J. Utrilla-Trigo S, et al. Among authors: jimenez cabello l. Vaccines (Basel). 2020 Jun 29;8(3):346. doi: 10.3390/vaccines8030346. Vaccines (Basel). 2020. PMID: 32610561 Free PMC article.
The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS21-180) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge.
Utrilla-Trigo S, Jiménez-Cabello L, Calvo-Pinilla E, Marín-López A, Lorenzo G, Sánchez-Cordón P, Moreno S, Benavides J, Gilbert S, Nogales A, Ortego J. Utrilla-Trigo S, et al. Among authors: jimenez cabello l. J Virol. 2022 Feb 9;96(3):e0161421. doi: 10.1128/JVI.01614-21. Epub 2021 Nov 17. J Virol. 2022. PMID: 34787454 Free PMC article.